Clinical Trial

Post-Acute Phase of Cardiogenic Shock

Recruiting
View on ClinicalTrials.gov →
Summary
Epidemiology studies showed that the burden of cardiogenic shock (CS) persistently high, with increasing annual medical expenses and steady prevalence. In-hospital and one-year mortality reduce annually. Hence, there are increasing number of patients who survive to hospital discharge but they will face further challenges in the subacute stage after hospital discharge. However, there are still insufficient studies focusing on this issue. Establishment of a healthcare neatwork to help hospital survivors of CS return society safely is critical.
Trial Details
NCT Number NCT07266675
Lead Sponsor Mackay Memorial Hospital
Conditions Cardiogenic Shock
Enrollment 350 participants
Start Date 2024-07-19
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-05